Oaktree Acquisition III Life Sciences Long Term Debt 2025-2024 | OACC

Oaktree Acquisition III Life Sciences long term debt from 2025 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Oaktree Acquisition III Life Sciences Annual Long Term Debt
(Millions of US $)
Oaktree Acquisition III Life Sciences Quarterly Long Term Debt
(Millions of US $)
2024-09-30
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.019B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00